← back to search

Arianeb Mehrabi

High Throughput Biology (United States) · DE
Area of research
Surgery · Hepatology
Research interest
Research interests include Organ Transplantation Techniques and Outcomes, Hepatocellular Carcinoma Treatment and Prognosis, Liver Disease and Transplantation, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
61
citations
15,482
works
695
NIH funding
primary concept
Medicine
email

Recent publications

Who Do We Fail to Rescue After Pancreatoduodenectomy? Outcomes Among >4000 Procedures Expose Windows of Opportunity.
2026cited by 8position: contributordoi
Preoperative Surgical or Endoscopic Bile Duct Drainage in Pancreatic Cancer.
2026cited by 2position: contributordoi
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
2025cited by 19position: contributordoi
Exploiting the Potential of Decellularized Extracellular Matrix (ECM) in Tissue Engineering: A Review Study.
2025cited by 18position: contributordoi
ChatGPT vs. surgeons on pancreatic cancer queries: accuracy & empathy evaluated by patients and experts.
2025cited by 9position: contributordoi
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigm.
2025cited by 4position: contributordoi
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer
Radiation Oncology 2025cited by 3position: middledoi
Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver Registry
Annals of Surgical Oncology 2025cited by 1position: middledoi
Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
2025cited by 0position: contributordoi
Management of bilioenteric anastomosis leakage after major liver resection.
2025cited by 0position: contributordoi
High versus low pneumoperitoneum PressUre for parenchymal transection in minimally invasive major liver surgery (PPULS)-a non-inferiority, multicenter, randomized, controlled trial.
2025cited by 0position: contributordoi
Aliado - A design concept of AI for decision support in oncological liver surgery.
2025cited by 0position: contributordoi
Exploring the Enhanced Liver Regeneration Patterns Following ALPPS Versus Selective Portal Vein Ligation in an Experimental Model.
2025cited by 0position: contributordoi
Short-term Outcomes of Robotic Versus Open Pancreatoduodenectomy: Propensity Score-matched Analysis.
2024cited by 28position: contributordoi
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data
Targeted Oncology 2024cited by 24position: middledoi
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.
2024cited by 21position: contributordoi
Distal Pancreatectomy: Extent of Resection Determines Surgical Risk Categories.
2024cited by 21position: contributordoi
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Journal of Clinical Oncology 2024cited by 19position: middledoi
Investigation of the morphological, physiological, biochemical, and catabolic characteristics and gene expression under drought stress in tolerant and sensitive genotypes of wild barley [Hordeum vulgare subsp. spontaneum (K. Koch) Asch. & Graebn.].
2024cited by 13position: contributordoi
Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences 2024cited by 11position: middledoi
Combined analysis of albumin in situ hybridisation and C reactive protein immunohistochemistry for the diagnosis of intrahepatic cholangiocarcinoma: towards a molecular classification paradigm
Journal of Clinical Pathology 2024cited by 10position: middledoi
Tranexamic Acid Administration During Liver Transplantation Is Not Associated With Lower Blood Loss or With Reduced Utilization of Red Blood Cell Transfusion.
2024cited by 8position: contributordoi
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
2024cited by 8position: contributordoi
Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
2024cited by 8position: contributordoi
Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial
JHEP Reports 2024cited by 7position: middledoi
Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation: Potentially modifiable risk factors with major clinical impact.
2024cited by 7position: contributordoi
S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV).
2024cited by 6position: contributordoi
Comparing a virtual reality head-mounted display to on-screen three-dimensional visualization and two-dimensional computed tomography data for training in decision making in hepatic surgery: a randomized controlled study.
2024cited by 6position: contributordoi
Aliado - A design concept of AI for decision support in oncological liver surgery
European Journal of Surgical Oncology 2024cited by 5position: middledoi
Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry
European Journal of Surgical Oncology 2024cited by 5position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 45 papers (2019–2025)Beat P. Müller‐Stich · University of Basel36 papers (2016–2024)Peter Schirmacher · Kliniken Essen-Mitte20 papers (2013–2024)Benjamin Goeppert · Kantonsspital Baselland19 papers (2013–2024)Christoph Springfeld · Université Grenoble Alpes17 papers (2019–2025)Stephanie Roessler · National Center for Tumor Diseases16 papers (2019–2025)Stéphanie Roessler · German Cancer Research Center14 papers (2013–2024)F Nickel · Universität Hamburg14 papers (2021–2025)Marcus Renner · German Cancer Research Center10 papers (2013–2019)Thomas Longerich · German Cancer Research Center10 papers (2019–2025)Albrecht Stenzinger · Chirurgische Universitätsklinik Heidelberg9 papers (2013–2022)Georg Lurje · Universitätsklinikum Aachen9 papers (2018–2025)Christoph Reissfelder · University Hospital Carl Gustav Carus9 papers (2021–2024)Markus W. Büchler · High Throughput Biology (United States)8 papers (2020–2024)Arne Warth · Heidelberg University8 papers (2013–2017)Lena Maier Hein · German Cancer Research Center8 papers (2013–2024)Wilko Weichert · German Cancer Research Center7 papers (2013–2016)Christoph Plass · German Cancer Research Center7 papers (2013–2021)Bruno Köhler · Heidelberg University7 papers (2019–2025)Keno März · German Cancer Research Center7 papers (2014–2024)